» 2008

Animal Health News & Notes for March 21, 2008 3/21/2008

printer friendly version

Brakke Consulting's
Animal Health News & Notes for March 21, 2008

Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon, DVM, MBA
Last week for early order pricing on the 2008 Pain Management Products for Dogs and Cats report
click here for details
earnings news
other news
Biogal Galed Labs
Catapult Genetics
DRE Veterinary
Fulton Provision Co.
Genovique Specialties
Live Tissue Connect
Modern Veterinary Therapeutics
Pain Management Products for Dogs and Cats - 2008
Coming in April!
Pain management is one of the leading topics in veterinary medicine today.  While pain management products for dogs and cats represented a minor part of the pharmaceuticals market a decade ago, they now represent a substantial market segment with potential still to be tapped. 
Brakke Consulting's annual report on Pain Management Products for Dogs and Cats includes such valuable information as:
  - overview of acute and chronic pain in small animals
  - review of products currently used to treat pain in dogs and cats
  - estimates of US sales and prices of leading pain management products
  - pain management products in development
  - new pain management products
  - review of nutritional supplements used for chronic pain
  - review of therapeutic diets for joint care
  - 2008 survey of over 200 small animal veterinarians regarding use of pain management products
Pain Management Products for Dogs and Cats 2008 can be purchased for $4,995 if ordered by March 31, 2008.  The report will be completed in April.  Questions about the study can be answered by project manager Lynn Fondon, DVM, MBA at 972-243-4033, or email Lfondon@brakkeconsulting.com
> Imugene reported results for the six months ended December 31, 2007.  Revenue for the period was Aus$212,833 (US$184,934), a 12% decrease from the previous year. The company reported a net loss of (Aus$1.3 million) for the period, compared to the (Aus$921,000) net loss reported in 2006. (Animal Pharm) 
Brakke Consulting is pleased to announce that Christine Merle, DVM, MBA, CVPM, was recently chosen by NAVC registrants as 2008 NAVC Practice Management Speaker of the Year.
Brakke Consulting's Veterinary Practice Management Group can help your company increase its value to existing and potential veterinary customers through sponsored seminars that are educational, relevant, enjoyable and very beneficial to veterinarians and their staffs. 
Dr. Merle is currently available for 2008 and 2009 speaking engagements.  For more information, contact Dr. Merle at 317-769-4494 or by email at cmerle@brakkeconsulting.com to learn how our practice management consultants can help maximize your company’s exposure to the veterinary profession.
> Pfizer Animal Health announced it will acquire two livestock genomics companies: Catapult Genetics, Pty., Ltd., and Bovigen, LLC.  Catapult develops and commercializes innovative livestock DNA tests and gene markers; Bovigen markets DNA technology, including Catapult’s products, in the US and throughout Canada, Central America and South America.  The acquisitions are expected to close by the end of this month.  Terms of the agreements were not disclosed. (Business Wire)
> Modern Veterinary Therapeutics (MVP) announced that it has received USDA approval for its ImmunoComb-FIP antibody diagnostic test for Feline Infectious Peritonitis.  The test is the result of a collaboration between MVP and Biogal Galed Labs of Israel.  (company press release) 
> DRE Veterinary announced it has expanded its product line of vet anesthesia machines to include the DRE Titan, a large animal anesthesia system. The Titan is ideal for anesthetizing equine, bovine and zoological animals. The Titan is available with an optional foal absorber that considerably reduces trapped volume for smaller animals that weigh between 25 and 600 pounds. (PRNewswire) 
> Royal DSM N.V. announced the sale of DSM Special Products to Arsenal Capital Partners.  DSM Special Products, with estimated sales of $150 million, manufactures specialty ingredients used in food, pharma and animal feed as well as a range of industrial applications. The sale does not include the DSM Nutritional Products division.  The new company will be renamed Genovique Specialties B.V. and will be based in Holland.  Financial terms were not disclosed. (Feedstuffs) 
> CSMG Technologies, Inc. announced it has added a veterinary subsidiary under its tissue welding technology subsidiary Live Tissue Connect (LTC). The new subsidiary is focused on the surgical treatment of animals using the company’s tissue welding technology. US, Australian, Canadian, Ukraine and EU patents have been issued, and additional patents are pending. (Business Wire)
> Sysco-owned meat processor Fulton Provision Co. has become the first meat processor and distributor in the US to be certified for sustainable business practices by the nonprofit certification group Food Alliance.  To become a Food Alliance certified processor and distributor, Fulton Provision underwent a third-party audit of their facilities that covered a range of concerns, including, food handling and safety, waste management, recycling, worker conditions and energy and water conservation. Fulton Provision supplies fresh and cooked beef products in eight western states. (Meating Place) 
> EUROPE   Jurox Pty. Ltd. and VĂ©toquinol SA  confirmed that the European launch of Alfaxan (alfaxalone), an injectable anaesthetic used for the induction and maintenance of anesthesia in cats and dogs, will proceed in the next few months. Alfaxan was launched in the UK 14 months ago. (Business Wire)
> US - MEAT PRODUCTION   Total US meat production set a record in 2007; according to the USDA, production reached 48.8 billion pounds for the year, up 2% from a year ago. Pork production, at 22 billion pounds, was 4% above 2006.  Beef totaled 26.5 billion pounds, up 1% from 2006. Veal and lamb production was down. (Pork Alert)
> USDA's Cooperative State Research, Education, and Extension Service (CSREES) awarded the Johne's Disease Integrated Program $4.8 million in renewed funding to control and ultimately eliminate the disease The continuation of the program will focus on developing new diagnostic tests, vaccines and strategies to help producers manage, control and prevent the disease
The USDA’s Animal and Plant Health Inspection Service (APHIS) announced the availability of $5.2 million in emergency funding to control outbreaks of cattle fever ticks occurring outside a permanent quarantine zone between Texas and Mexico created to prevent the ticks from becoming established in the USAlthough outbreaks of cattle fever ticks are expected in the quarantine zone, the number of outbreaks has increased recently. Outbreaks have also occurred outside the quarantine zone, which is of greatest concern. (AnimalNet)
The news this week is a little light; perhaps folks are on Spring Break.  But what news there is continues to emphasize some of the trends we identified in our Industry Overview presentation. 
On another Brakke front, congratulations to our own Christine Merle for her selection as 2008 NAVC Practice Management Speaker of the Year.  If your company wants to make more of an impression on veterinarians, Christine is obviously a good choice for corporate-sponsored speaking and consulting. 

Enjoy the weekend.
John Mannhaupt, Dallas
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting's services and syndicated studies, visit our website at www.brakkeconsulting.com.
Brakke Consulting, Inc.
2735 Villa Creek, Suite 140
Dallas, TX  75234    USA